[1] MOEINI A,SIA D,BARDEESY N,et al.Molecular pathogenesis and targeted therapies for intrahepatic cholangiocarcinoma[J].Clin Cancer Res,2016,22(2):291-300.
[2] KE Q,LIN N,DENG M,et al.The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection:A systematic review and meta-analysis[J].PLoS One,2020,15(2):e0229292.
[3] SIRICA AE,GORES GJ,GROOPMAN JD,et al.Intrahepatic cholangiocarcinoma:Continuing challenges and translational advances[J].Hepatology,2019,69(4):1803-1815.
[4] 尤文化,梁渊,吕凌.精准医学时代下肝内胆管癌的发病机制与临床转化[J].临床肝胆病杂志,2021,37(04):935-938.
YOU Wenhua,LIANG Yuan,LYU Ling.Pathogenesis and clinical transformation of intrahepatic cholangiocarcinoma in the era of precision medicine[J].Journal of Clinical Hepatobiliary Diseases,2021,37(04):935-938.
[5] JIN J,CARDOZO T,LOVERING RC,et al.Systematic analysis and nomenclature of mammalian F-box proteins[J].Genes Dev,2004,18(21):2573-2580.
[6] SCHMIDT A,DUNCAN PI,RAUH NR,et al.Xenopus polo-like kinase Plx1 regulates XErp1,a novel inhibitor of APC/C activity[J].Genes Dev,2005,19(4):502-513.
[7] NAKAYAMA KI,NAKAYAMA K.Ubiquitin ligases:cell-cycle control and cancer[J].Nat Rev Cancer,2006,6(5):369-381.
[8] XU B,LYU W,LI X,et al.Prognostic genes of hepatocellular carcinoma based on gene coexpression network analysis[J].J Cell Biochem,2019,120(7):11616-11623.
[9] HEIM A,TISCHER T,MAYER TU.Calcineurin promotes APC/C activation at meiotic exit by acting on both XErp1 and Cdc20[J].EMBO Rep,2018,19(12):e46433.
[10] OHE M,KAWAMURA Y,UENO H,et al.Emi2 inhibition of the anaphase-promoting complex/cyclosome absolutely requires Emi2 binding via the C-terminal RL tail[J].Mol Biol Cell,2010,21(6):905-913.
[11] SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics,2020[J].CA Cancer J Clin,2020,70(1):7-30.
[12] YU Y,LIU Q,LI W,et al.Identification of a novel EHBP1-MET fusion in an intrahepatic cholangiocarcinoma responding to crizotinib[J].Oncologist,2020,25(12):1005-1008.
[13] WARDELL CP,FUJJTA M,YAMADA T,et al.Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations[J].J Hepatol,2018,68(5):959-969.
[14] TATE JG,BAMFORD S,JUBB HC,et al.COSMIC:the catalogue of somatic mutations in cancer[J].Nucleic Acids Res,2019,47(D1):D941-D947.
[15] BOONSRI B,YACQUB-USMAN K,THINTHARUA P,et al.Effect of combining EGFR tyrosine kinase inhibitors and cytotoxic agents on cholangiocarcinoma cells[J].Cancer Res Treat,2021,53(2):457-470.
[16] LAMBERTI D,CRISTINZIANO G,PORRU M,et al.HSP90 inhibition drives degradation of FGFR2 fusion proteins:Implications for treatment of cholangiocarcinoma[J].Hepatology,2019,69(1):131-142.
[17] MADGWICK S,JONES KT.How eggs arrest at metaphase Ⅱ:MPF stabilisation plus APC/C inhibition equals cytostatic factor[J].Cell Div,2007,2:4.
[18] JANG SH,KIM AR,PARK NH,et al.DRG2 regulates G2/M progression via the Cyclin B1-Cdk1 complex[J].Mol Cells,2016,39(9):699-704.
[19] GOPINATHAN L,SZMYD R,LOW D,et al.Emi2 is essential for mouse spermatogenesis[J].Cell Rep,2017,20(3):697-708.
[20] 邓刚,蔡谭兴,雷钊,等.SALL4基因在肝内胆管癌中通过抑制KLF4基因表达促进EMT改变[J].肿瘤药学,2021,11(01):36-39.
DENG Gang,CAI Tanxing,LEI Zhao,et al.SALL4 gene promotes EMT by inhibiting KLF4 gene expression in intrahepatic cholangiocarcinoma[J].Oncology Pharmacy,2021,11(01):36-39.
[21] 周闯,陆旭,宋盛平,等.PKM2对肝内胆管癌细胞增殖及上皮间质化的影响[J].西安交通大学学报(医学版),2021,42(01):25-29.
ZHOU Chuang,LU Xu,SONG Shengping,et al.Effect of PKM2 on proliferation and epithelial-mesenchymal differentiation of intrahepatic bile duct cancer cells[J].Journal of Xi'an Jiaotong University(Medical Science Edition),2021,42(01):25-29.
[22] PAN S,HU Y,HU M,et al.Platelet-derived PDGF promotes the invasion and metastasis of cholangiocarcinoma by upregulating MMP2/MMP9 expression and inducing EMT via the p38/MAPK signalling pathway[J].Am J Transl Res,2020,12(7):3577-3595.
[23] ZHAO H,DESAI V,WANG J,et al.Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines[J].Mol Cancer Ther,2012,11(2):503-513.
[24] CHEN T,LI K,LIU Z,et al.WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways[J].Mol Ther,2021,29(06):2134-2150.
[25] SUWANNAKUL N,MA N,MIDORIKAWA K,et al.CD44v9 induces stem cell-like phenotypes in human cholangiocarcinoma[J].Front Cell Dev Biol,2020,8:417.